Primary Radiotherapy In MEtastatic Lung Cancer

Clinical trial NCT07135882 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07135882
Sponsor: Trans Tasman Radiation Oncology Group
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung (NSCLC)

Start date: 2026-08-25
Primary completion: 2030-12-31
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.